A randomized pilot study comparing zero-calorie alternate-day fasting to daily caloric restriction in adults with obesity
Catenacci VA, Pan Z, Ostendorf D, Brannon S, Gozansky WS, Mattson MP, Martin B, MacLean PS, Melanson EL, Troy Donahoo W
Obesity (Silver Spring, Md.) · 251 citas
Cómo se estudió
- Diseño
- Ensayo controlado aleatorizado (indexado por PubMed)
- Estudiado en
- Personas
- Resultado principal
- Marcadores de salud y funcionamiento
Quién lo pagó
- Financiación
- Financiación independiente
- Gobierno
- National Institutes of Health
- Gobierno
- National Institute on Aging
- Gobierno
- National Institute of Diabetes and Digestive and Kidney Diseases
- Gobierno
- National Center for Advancing Translational Sciences
- Gobierno
- National Center for Complementary and Integrative Health
- Gobierno
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Gobierno
- NIDDK NIH HHS
- Gobierno
- NCATS NIH HHS
- Gobierno
- NICHD NIH HHS
- Gobierno
- NCCIH NIH HHS
- Subvenciones
- National Institute of Diabetes and Digestive and Kidney Diseases (P30 DK048520); Eunice Kennedy Shriver National Institute of Child Health and Human Development (P50 HD073063); National Center for Advancing Translational Sciences (UL 1 TR001082); National Center for Complementary and Integrative Health (R21 AT002617); National Institute of Diabetes and Digestive and Kidney Diseases (K01 DK067403); National Institutes of Health (UL1-TR-001082); National Institutes of Health (TR001082); National Institutes of Health (NIH UL1 TR001082); National Institutes of Health (R21 AT002617‐02); National Institutes of Health (R21 AT002617‐02, NIH UL1 TR001082, NIH DK 048520); National Institutes of Health (NIH-DK048520)
Según 10 financiadores declarados.
Publicación
- Publicado
- 2016-08-29 · Obesity (Silver Spring) · vol. 24 · número 9 · págs. 1874–1883
- Editorial
- Wiley
- Citado
- 332 citas · más que el 99% de estudios similares · 11.9× el promedio de su campo
- Impacto
- Entre el 10 % más citado de su campo
- Referencias
- 39 trabajos
- Acceso
- Lectura gratuita
- Áreas de investigación
- Dietary Effects on Health · Genetics, Aging, and Longevity in Model Organisms · Diet and metabolism studies
- Palabras clave
- Caloric theory, Calorie, Medicine, Low calorie diet, Obesity, Caloric intake, Randomized controlled trial, Calorie restriction, Gerontology, Weight loss, Internal medicine
- MeSH
- humans, obesity, body weight, weight loss, treatment outcome, caloric restriction, diet, reducing, fasting, pilot projects, body composition, energy intake, adult, middle aged, female, male
10 autores
- Victoria A. Catenacci🇺🇸 · autor de correspondenciaColorado School of Public Health; University of Colorado Anschutz
- Zhaoxing Pan🇺🇸Children's Hospital Colorado; University of Colorado Anschutz; University of Colorado Denver
- Danielle M. Ostendorf🇺🇸Colorado School of Public Health; University of Colorado Anschutz
- Sarah Brannon🇺🇸Colorado School of Public Health; University of Colorado Anschutz
- Wendolyn S. Gozansky🇺🇸Kaiser Permanente
- Mark P. Mattson🇺🇸National Institutes of Health; Johns Hopkins University; Johns Hopkins Medicine; Institute on Aging; National Institute on Aging
- Bronwen Martin🇺🇸National Institutes of Health; National Institute on Aging
- Paul S. MacLean🇺🇸Colorado School of Public Health; University of Colorado Anschutz
- Edward L. Melanson🇺🇸University of Colorado Anschutz
- William Troy Donahoo🇺🇸Kaiser Permanente; University of Colorado Anschutz
Resumen
El texto original del estudio, en el idioma en que se publicó.
Objective
To evaluate the safety and tolerability of alternate-day fasting (ADF) and to compare changes in weight, body composition, lipids, and insulin sensitivity index (Si) with those produced by a standard weight loss diet, moderate daily caloric restriction (CR).
Methods
Adults with obesity (BMI ≥30 kg/m(2) , age 18-55) were randomized to either zero-calorie ADF (n = 14) or CR (-400 kcal/day, n = 12) for 8 weeks. Outcomes were measured at the end of the 8-week intervention and after 24 weeks of unsupervised follow-up.
Results
No adverse effects were attributed to ADF, and 93% completed the 8-week ADF protocol. At 8 weeks, ADF achieved a 376 kcal/day greater energy deficit; however, there were no significant between-group differences in change in weight (mean ± SE; ADF -8.2 ± 0.9 kg, CR -7.1 ± 1.0 kg), body composition, lipids, or Si. After 24 weeks of unsupervised follow-up, there were no significant differences in weight regain; however, changes from baseline in % fat mass and lean mass were more favorable in ADF.
Conclusions
ADF is a safe and tolerable approach to weight loss. ADF produced similar changes in weight, body composition, lipids, and Si at 8 weeks and did not appear to increase risk for weight regain 24 weeks after completing the intervention.
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.